News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
829,346 Results
Type
Article (85474)
Company Profile (696)
Press Release (743176)
Section
Business (231966)
Career Advice (4103)
Deals (39642)
Drug Delivery (115)
Drug Development (90573)
Employer Resources (194)
FDA (17929)
Job Trends (17268)
News (395085)
Policy (39600)
Tag
Academia (2973)
Alliances (56410)
Alzheimer's disease (1317)
Approvals (17860)
Artificial intelligence (135)
Bankruptcy (394)
Best Places to Work (12468)
Biotechnology (480)
Breast cancer (114)
Cancer (1048)
Career advice (3511)
Cell therapy (252)
Clinical research (71346)
Collaboration (380)
Compensation (182)
COVID-19 (2789)
C-suite (93)
Data (1042)
Diabetes (128)
Diagnostics (6607)
Drug pricing (89)
Earnings (94293)
Employer resources (166)
Events (126283)
Executive appointments (287)
FDA (18395)
Funding (320)
Gene therapy (189)
GLP-1 (646)
Government (5031)
Healthcare (20648)
Infectious disease (2858)
Inflammatory bowel disease (120)
Interviews (807)
IPO (17556)
Job creations (5177)
Job search strategy (2854)
Layoffs (484)
Legal (10025)
Lung cancer (168)
Manufacturing (186)
Medical device (14275)
Medtech (14280)
Mergers & acquisitions (22056)
Metabolic disorders (394)
Neuroscience (1602)
NextGen Class of 2024 (7645)
Non-profit (5054)
Northern California (1352)
Obesity (221)
Opinion (244)
Patents (102)
People (64061)
Pharmaceutical (138)
Phase I (21965)
Phase II (31005)
Phase III (23360)
Pipeline (434)
Postmarket research (3534)
Preclinical (9937)
Radiopharmaceuticals (247)
Rare diseases (223)
Real estate (7369)
Regulatory (25866)
Research institute (2637)
Resumes & cover letters (648)
Southern California (1217)
Startups (4273)
United States (12946)
Vaccines (619)
Weight loss (181)
Date
Today (106)
Last 7 days (698)
Last 30 days (3359)
Last 365 days (36234)
2024 (33014)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1264)
Arizona (213)
Asia (49256)
Australia (8687)
California (3128)
Canada (1205)
China (240)
Colorado (109)
Connecticut (132)
Europe (112779)
Florida (388)
Georgia (92)
Illinois (363)
Indiana (187)
Kansas (103)
Maryland (596)
Massachusetts (2596)
Michigan (144)
Minnesota (251)
New Jersey (938)
New York (877)
North Carolina (801)
Northern California (1352)
Ohio (127)
Pennsylvania (790)
South America (1646)
Southern California (1217)
Texas (418)
Washington State (360)
829,346 Results for "sk bio pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
October 24, 2024
·
3 min read
Press Releases
South Korea’s SK bioscience Completes Acquisition of Germany’s CDMO IDT Biologika
October 2, 2024
·
6 min read
Business
Ferring Pharmaceuticals and SK Pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring long-term future supply.
April 18, 2024
·
10 min read
Press Releases
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
November 19, 2024
·
5 min read
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada
SK Biopharmaceuticals Co., Ltd. today announced more than 100,000 patients have been treated globally with cenobamate, an anti-seizure medication (ASM) developed by SK Biopharmaceuticals and its U.S. subsidiary SK Life Science, Inc.
March 11, 2024
·
13 min read
SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has obtained prequalification certification from the World Health Organization for its typhoid conjugate vaccine, ‘SKYTyphoid®'.
February 23, 2024
·
4 min read
Press Releases
SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production
September 30, 2024
·
3 min read
SK Inc. hosts “SK Bio Night” in San Francisco to expand global partnerships
SK Inc., together with its life science affiliates including SK biopharmaceuticals and SK pharmteco, will hold a networking event to expand their global partnerships in the U.S., the world’s largest bio and pharmaceutical market.
January 9, 2023
·
4 min read
Africa CDC Director General Visits SK bioscience to Discuss Vaccine Localization in Africa
SK bioscience announced that H.E Dr. Jean Kaseya, Director General of Africa CDC visited SK bioscience headquarters on November 3 to discuss collaboration with the Partnerships for African Vaccine Manufacturing.
November 5, 2023
·
4 min read
Biotech Bay
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at ‘SK Bio Night’
SK Inc.'s 1st SK Bio Night on the sidelines of J.P. Morgan Healthcare Conference offers a glimpse into the future of its global business in new drug, CDMO, biotech.
January 9, 2023
·
4 min read
1 of 82,935
Next
